XVI International HIV Drug Resistance Workshop

WORKSHOP ORGANIZATION

Organizing Committee

Charles Boucher, Chair University Hospital Utrecht, the Netherlands	Brendan Larder RDI, UK
John Mellors, Co-chair University of Pittsburgh, USA	Douglas Richman University of California San Diego/ VA Medical Center, USA

Scientific Committee

Lee Bacheler
VircoLab, Inc, USA

Ralf Bartenschlager
University of Heidelberg, Germany

Nick Cammack
Roche Palo Alto, USA

François Clavel
Inserm U552, France

Bonaventura Clotet
Fundacio IRSI Caixa, Spain

John Coffin
National Cancer
Institute-Frederick, USA

Dominique Costagliola
INSERM U720 and Université Pierre et Marie Curie, France

Robert Grant
Gladstone/UCSF, USA

Michael Greenberg
Trimeris, Inc., USA

Richard Harrigan
BC Centre For Excellence
in HIV/AIDS, Canada

Daria Hazuda
Merck Research Labs, USA

Nicholas Hellmann
Bill & Melinda Gates
Foundation, USA

Kurt Hertogs
Tibotec bvba, Belgium

Dale Kempf
Abbott, USA

Daniel Kuritzkes
Brigham and Women's Hospital, USA

Randall Lanier
GlaxoSmithKline, USA

Susan Little
University of California, San Diego, USA

Stephen Locarnini
VIDRL, Australia

Douglas Mayers
Idenix Pharmaceuticals, USA

Michael Miller
Gilead Sciences, USA

Christos Petropoulos
Monogram Biosciences, USA

Deenan Pillay
University College London, UK

Jonathan Schapiro
National Hemophilia Center - Israel, Israel

Raymond Schinazi
Emory University/VA Medical Center, USA

David Stammers
University of Oxford, UK

Mark Wainberg
McGill University AIDS Centre, Canada

Mike Westby
Pfizer Global R&D, UK

Andrew Zolopa
Stanford University, USA